Skip to main content

IncellDx PD-L1 Assay

IncellDx has released a new single-cell PD-L1 assay for research use only. The new "OncoTect iO Quantitative" test kit includes labeled antibodies to PD-L1 and CD45, CD8, and CD3 cell subsets as well as a DNA dye for cell cycle and quantitative detection of PD-L1 expression in non-small cell lung cancer tissue. According to the company, kits can be used on numerous samples types including FNA, core biopsies, and blood. The assay is also applicable to tumor types other than NSCLC including lung, bladder, and head and neck cancers.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.